Biora Therapeutics Achieves ISO 13485 Certification, Demonstrating The Co's Commitment To Compliance With The Most Rigorous Global Regulatory And Quality Standards
Author: Benzinga Newsdesk | September 09, 2024 08:13am
Biora Therapeutics, Inc. (NASDAQ:BIOR), the biotech company reimagining therapeutic delivery, today announced it has been awarded ISO 13485:2016 certification by TÜV SÜD America, demonstrating the company's commitment to compliance with the most rigorous global regulatory and quality standards.
Posted In: BIOR